Skip to content

Combination of dexmedetomidine and timing propofol inhibited the ED50/ED95 of expanded uterine motor response in hysteroscopy patients

Combination of dexmedetomidine and timing propofol inhibited the ED50/ED95 of expanded uterine motor response in hysteroscopy patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039747
Enrollment
Unknown
Registered
2020-11-07
Start date
2020-11-09
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopic intravenous anesthesia

Interventions

1:Propofol 1.6 mg/kg
2:Propofol 1.8 mg/kg
3:Propofol 2.0 mg/kg
4:Propofol 2.2 mg/kg
5:Propofol 2.4 mg/kg
6:Propofol 2.6 mg/kg
7:Dexmedetomidine 0.5ug /kg propofol 1.0mg /kg
8:Dexmedetomidine 0.5ug /kg propofol 1.2mg /kg
9:Dexmedetomidine 0.5ug /kg propofol 1.4mg /kg
10:Dexmedetomidine 0.5ug /kg propofol 1.6mg /kg
11:Dexmedetomidine 0.5ug /kg propofol 1.8mg /kg
12:Dexmedetomidine 0.5ug /kg propofol 1.8mg /kg

Sponsors

Ningbo Medical Center Li Huili Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged 19~60 years, ASA I~II, no abnormal surgical anesthesia history, no neuromuscular system disease, no neuropsychiatric disease.

Exclusion criteria

Exclusion criteria: Suspected difficult airway, history of gastroesophageal reflux, recent respiratory infection, BMI > 30kg/m2, severe emasculation, history of drug allergy.

Design outcomes

Primary

MeasureTime frame
Body moving;

Secondary

MeasureTime frame
Heart rate;Blood pressure;Oxygen saturation;Pain score;

Countries

China

Contacts

Public ContactXu-Feng zhang

Ningbo Medical Center Li Huili Hospital

214019572@qq.com+86 13732196953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026